Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

Falkor, a novel cell growth regulator isolated by a functional genetic screen

Abstract

A novel cell growth regulator, named Falkor, was identified using a functional approach to mammalian gene cloning, the Genetic Supressor Elements (GSE) method. In this screen, expression of the C-terminal domain of Falkor conferred cells with resistance to cisplatin-induced growth arrest. Expression of the C-terminus of Falkor, but not of the full-length protein, enhanced cell growth both following genotoxic stress and under normal conditions suggesting a general role for this protein in cell growth control. This effect of the C-terminus fragment was abrogated by over-expression of the full-length Falkor, suggesting that the fragment counteracts the function of the full-length protein. Falkor is encoded by a 2-kb mRNA which is present at different levels in various tissues, and is localized in the nucleus of cells. The C-terminal domain of Falkor, isolated from the GSE library, has significant homology to a known human and rat cell growth regulator, SM-20, and to the C. elegans protein EGL-9, recently shown to modify the Hypoxia Inducible Factor-1α. The homology suggests that these proteins share a functional domain that is conserved among a family of growth regulation proteins.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6

Similar content being viewed by others

References

  • Amundson SA, Myers TG, Fornace Jr AJ . 1998 Oncogene 17: 3287–3299

  • Aravind L, Koonin EV . 2001 Genome Biol. 2: 0007.1–0008.1

  • Bruick RK, McKnight SL . 2001 Science 294: 1337–1340

  • Bunz F, Dutriaux A, Lengauer C, Waldman T, Zhou S, Brown JP, Sedivy JM, Kinzler KW, Vogelstein B . 1998 Science 282: 1497–1501

  • Dupuy D, Aubert I, Duperat VG, Petit J, Taine L, Stef M, Bloch B, Arveiler B . 2000 Genomics 69: 348–354

  • Epstein AC, Gleadle JM, McNeill LA, Hewitson KS, O'Rourke J, Mole DR, Mukherji M, Metzen E, Wilson MI, Dhanda A, Tian YM, Masson N, Hamilton DL, Jaakkola P, Barstead R, Hodgkin J, Maxwell PH, Pugh CW, Schofield CJ, Ratcliffe PJ . 2001 Cell 107: 43–54

  • Evan GI, Vousden KH . 2001 Nature 411: 342–348

  • Foca C, Rice GE, Quinn MA, Moses EK . 2000 Mol. Hum. Reprod. 6: 712–718

  • Gudkov A, Kazarov A, Thimmapaya R, Axenovich S, Mazo IA, Robinson I . 1994 PNAS 91: 3744–3748

  • Hoeijmakers JH . 2001 Nature 411: 366–374

  • Jamerson MH, Johnson MD, Dickson RB . 2000 Oncogene 19: 1065–1071

  • Kastan MB, Onyekwere O, Sidransky D, Vogelstein B, Craig RW . 1991 Cancer Res. 51: 6304–6311

  • Lipscomb E, Sarmiere P, Crowder R, Freeman R . 1999 J. Neurochem. 73: 429–432

  • Lipscomb EA, Sarmiere PD, Freeman RS . 2001 J. Biol. Chem. 276: 5085–5092

  • Madden S, Galella E, Riley D, Bertelson A, Beaudry G . 1996 Cancer Res. 56: 5384–5390

  • Patanjali SR, Parimoo S, Weissman SM . 1991 Proc. Natl. Acad. Sci. USA 88: 1943–1947

  • Pear WS, Nolan GP, Scott ML, Baltimore D . 1993 Proc. Natl. Acad. Sci. USA 90: 8392–8396

  • Seth P, Krop I, Porter D, Polyak K . 2002 Oncogene 21: 836–843

  • Stanelle J, Stiewe T, Theseling CC, Peter M, Putzer BM . 2002 Nucleic Acids Res. 30: 1859–1867

  • Taylor MS . 2001 Gene 275: 125–132

  • Wax SD, Rosenfield C, Taubman MB . 1994 J. Biol. Chem. 269: 13041–13047

  • Wax SD, Tsao L, Lieb ME, Fallon JT, Taubman MB . 1996 Lab. Invest. 74: 797–808

  • Wei YF, Carter KC, Wang RP, Shell BK . 1996 Nucleic Acids Res. 24: 931–937

Download references

Acknowledgements

We thank Dr Tal Raveh for critical reading of the manuscript. The authors would like to thank Noam Erez for his help with the cell staining and microscopic analysis. This work was supported in part by grants from the Israel-USA Binational Science Foundation (BSF) and the German Israeli Foundation for Sciencific Research and Development (GIF). V Rotter is the incumbent of the Normal and Helen Asher Professorial Chair in Cancer Research at the Weizmann Institute. N Erez was awarded an UICC ICRETT grant (No. 992).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Varda Rotter.

Additional information

The nucleotide sequence reported in this study was submitted to the GenBank with accession number AF340231.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Erez, N., Milyavsky, M., Goldfinger, N. et al. Falkor, a novel cell growth regulator isolated by a functional genetic screen. Oncogene 21, 6713–6721 (2002). https://doi.org/10.1038/sj.onc.1205867

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1205867

Keywords

Search

Quick links